Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 21, 2023

BUY
$31.86 - $67.26 $2,962 - $6,255
93 New
93 $4,000
Q1 2023

Apr 25, 2023

BUY
$45.44 - $74.26 $4,225 - $6,906
93 New
93 $6,000
Q4 2017

Jan 23, 2018

SELL
$37.27 - $43.02 $5,105 - $5,893
-137 Closed
0 $0
Q3 2017

Oct 10, 2017

BUY
$33.75 - $41.67 $4,623 - $5,708
137
137 $6,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.